Glenmark Pharmaceuticals board to consider Unaudited Financial Results

14 Jan 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2006.85 -0.05 (0.00%)
30-Dec-2025 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.00
Dr. Reddys Lab 1267.30
Cipla 1488.30
Zydus Lifesciences 900.80
Lupin 2078.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×